Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Catalent Maryland, Inc.
EIR
•Catalent Maryland, Inc.•November 4, 2019

Catalent Maryland, Inc. – FDA EIR, Nov 4, 2019

Record Details

A U.S. Food and Drug Administration (FDA) inspection of Catalent Maryland, a contract development manufacturer of biological drug products, was conducted from October 28 to November 4, 2019. The inspection, performed under guidance for biological drug products (CPGM 7345.848), covered quality, facilities, equipment, materials, production, and laboratory control systems. Key deficiencies, formally documented on a Form FDA 483, included inadequate procedures to prevent microbiological contamination of sterile drug products. Specifically, the company lacked dynamic smoke studies for an ISO 5 biosafety cabinet, experienced a lapse in cleanroom certification, and did not consistently use sterile wipes or sporicidal agents in ISO 5 areas. Additionally, written records for investigations into unexplained discrepancies, such as product color variations, were often incomplete, failing to include thorough root cause assessments (referencing 21 CFR 211.192). Verbal observations highlighted further concerns, including ineffective corrective actions, poor document control, lack of documentation for facility repairs, environmental cleanliness issues, and delays in closing investigations. Inadequate handwashing procedures for personnel entering GMP manufacturing areas were also noted. Catalent Maryland's management acknowledged these observations and committed to submitting a written response to the FDA within 15 business days, outlining corrective and preventive actions.

Company
Catalent Maryland, Inc.
Inspection date
November 4, 2019
Product type
biologics
Office
Division of Biological Products Operations I
People
  • Sharon Turner-Rinehardt (company_representative)
  • Tom Bujold (company_representative)
  • Mindy M. Chou
  • Isis Barahona (company_representative)
  • Randy R. Henrickson (recipient)
View Company Profile

ID · 1c66c720-1615-44ba-a10b-ba9ea57928a5

Violation Codes3
21 CFR 820.10021 CFR 211.19221 CFR 820.50

Full citation text and observation details available on the Dashboard.

Other documents for Catalent Maryland, Inc.
  • 483 - 2025-04-09April 9, 2025
  • 483 - 2019-11-04November 4, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Catalent Maryland, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.